AU2001260834A1 - The treatment of herpes - Google Patents
The treatment of herpesInfo
- Publication number
- AU2001260834A1 AU2001260834A1 AU2001260834A AU6083401A AU2001260834A1 AU 2001260834 A1 AU2001260834 A1 AU 2001260834A1 AU 2001260834 A AU2001260834 A AU 2001260834A AU 6083401 A AU6083401 A AU 6083401A AU 2001260834 A1 AU2001260834 A1 AU 2001260834A1
- Authority
- AU
- Australia
- Prior art keywords
- herpes
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ504526A NZ504526A (en) | 2000-05-12 | 2000-05-12 | Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate |
NZ504526 | 2000-05-12 | ||
PCT/NZ2001/000086 WO2001085164A1 (en) | 2000-05-12 | 2001-05-11 | The treatment of herpes |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001260834A1 true AU2001260834A1 (en) | 2001-11-20 |
Family
ID=19927882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001260834A Abandoned AU2001260834A1 (en) | 2000-05-12 | 2001-05-11 | The treatment of herpes |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001260834A1 (en) |
NZ (1) | NZ504526A (en) |
WO (1) | WO2001085164A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030153620A1 (en) | 2000-05-12 | 2003-08-14 | Meakin Timothy David | Treating eczema and/or psoriasis |
NZ533370A (en) | 2004-06-03 | 2006-11-30 | Meracol Corp Ltd | Use of cetyl myristate and cetyl palmitate in therapy for multiple sclerosis |
EP2441441A1 (en) | 2010-10-14 | 2012-04-18 | Deva Holding Anonim Sirketi | A sieving method for cetyl myristate and/or cetyl palmitate |
EP2583673A1 (en) | 2010-10-14 | 2013-04-24 | Deva Holding Anonim Sirketi | Coating of cetyl myristate and/or cetyl palmitate particles |
EP2441444A1 (en) | 2010-10-14 | 2012-04-18 | Deva Holding Anonim Sirketi | Formulations of cetyl myristate and/or cetyl palmitate |
EP2441446A1 (en) | 2010-10-14 | 2012-04-18 | Deva Holding Anonim Sirketi | Using of superdisintegrants in cetyl myristate and/or cetyl palmitate formulations |
EP2471387A1 (en) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Cetyl myristate and/or cetyl palmitate suspension formulations |
EP2471386A1 (en) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Cetyl myristate and/or cetyl palmitate suspension formulations |
EP2471384A1 (en) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Suspension formulations of cetyl myristate and/or cetyl palmitate |
EP2471528A1 (en) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | A preparation method for suspension of cetyl myristate and/or cetyl palmitate |
EP2471514A1 (en) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Controlled moisture content of cetyl myristate and/or cetyl palmitate granules or formulations |
EP2471385A1 (en) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Cetyl myristate and/or cetyl palmitate suspension formulations |
EP2526931B1 (en) | 2011-05-23 | 2014-12-17 | Deva Holding Anonim Sirketi | Wet granulation methods of cetyl myristate and/or cetyl palmitate |
ES2538079T3 (en) | 2011-05-23 | 2015-06-17 | Deva Holding Anonim Sirketi | Particle size distribution of cetyl myristate and / or cetyl palmitate |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU195729B (en) * | 1985-02-05 | 1988-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides |
DE4308282C2 (en) * | 1993-03-16 | 1994-12-22 | Beiersdorf Ag | Galenic matrices preferably in the form of microspheres |
DE19819273A1 (en) * | 1998-04-30 | 1999-11-11 | Pharmatec International S Giul | Pharmaceutical ciclosporin formulation with improved biopharmaceutical properties, increased physical quality and stability as well as processes for its manufacture |
EP1080226A4 (en) * | 1998-05-21 | 2004-04-21 | Isis Pharmaceuticals Inc | Compositions and methods for topical delivery of oligonucleotides |
GB9810949D0 (en) * | 1998-05-22 | 1998-07-22 | Hewlett Healthcare Limited | Formulation |
US6284234B1 (en) * | 1998-08-04 | 2001-09-04 | Johnson & Johnson Consumer Companies, Inc. | Topical delivery systems for active agents |
TR200103188T2 (en) * | 1999-05-07 | 2002-04-22 | Pharmasol Gmbh | Lipid particles based on liquid and solid lipid mixtures. |
-
2000
- 2000-05-12 NZ NZ504526A patent/NZ504526A/en not_active IP Right Cessation
-
2001
- 2001-05-11 AU AU2001260834A patent/AU2001260834A1/en not_active Abandoned
- 2001-05-11 WO PCT/NZ2001/000086 patent/WO2001085164A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001085164A1 (en) | 2001-11-15 |
NZ504526A (en) | 2003-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002223827A1 (en) | Well treatment | |
AU2002327620A1 (en) | Defibrillators | |
AU2001252135A1 (en) | Therapeutic agents | |
AU2001245965A1 (en) | Large body stretcher | |
AU5089400A (en) | Arthritis treatment | |
AU2001259702A1 (en) | Tissue regrafting | |
AU1772399A (en) | Well treatment | |
AU2001260834A1 (en) | The treatment of herpes | |
AU2002231206A1 (en) | Treatment of depression | |
AU2001226910A1 (en) | Electrolytic treatment | |
AU5547000A (en) | Novel treatment | |
AU2002319650A1 (en) | Defibrillators | |
AU2002227925A1 (en) | Human beta-defensin-3 | |
AU2001270129A1 (en) | Human phosphodiesterases | |
AU2001236929A1 (en) | Surface treatment | |
AU4556800A (en) | Novel treatment | |
AU2002335667A1 (en) | Modified reoviral therapy | |
AU2001273903A1 (en) | Therapeutic agents | |
AU2001257325A1 (en) | Cancer treatment | |
AU2001261324A1 (en) | Psoriasis treatment | |
AU3714800A (en) | Hiv therapy | |
AU4456800A (en) | Human hac3 | |
AU2001292897A1 (en) | Novel therapy | |
AU2001289127A1 (en) | Tumor treatment | |
AU2001253560A1 (en) | Methods of treatment |